Laboratory of America LH releases its next round of earnings Wednesday. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.
Earnings and Revenue
Sell-side analysts expect Laboratory of America's EPS to be near $2.94 on sales of $2.85 billion.
If the company were to match the consensus estimate when it reports Wednesday, earnings would be up 19.03 percent. Sales would be up 14.09 percent on a year-over-year basis. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:
Quarter | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
EPS Estimate | 2.63 | 2.38 | 2.39 | 2.4 |
EPS Actual | 2.78 | 2.45 | 2.46 | 2.47 |
Stock Performance
Over the last 52-week period, shares are up 20.26 percent. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The most common rating by analysts on Laboratory of America stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Laboratory of America's Q2 conference call is scheduled to begin at 9:00 a.m. ET and can be accessed here: http://phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.